Welcome to our dedicated page for Lifevantage news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage stock.
LifeVantage Corporation reports developments for a health and wellness company built around nutrigenomics, dietary supplements, skin and hair care products, nootropic energy drink mixes, and pet supplements. Its product line includes Protandim, TrueScience Liquid Collagen, MindBody GLP-1 System, LoveBiome P84, AXIO, TrueScience skin and hair care products, and Petandim, sold through independent Consultants to customers.
Company news commonly covers quarterly results, regional sales trends, product innovation, patents tied to cellular-signaling supplement compositions, consultant events and training, international market expansion, executive leadership changes, share repurchases, and cash dividends. Updates also describe capital allocation and the company’s direct-selling business model.
LifeVantage (Nasdaq: LFVN) hosted its global Activate 2024 virtual event on July 20, 2024, reaffirming its commitment to the direct selling industry. The event highlighted the company's transformation and focus on modern direct selling through its LV360 initiative. CEO Steve Fife teased a major product launch set for October 2024 - an innovative weight loss product designed to suppress food cravings and balance hunger hormones through cellular activation.
The event emphasized the company's Rise ERA strategy (Enrolling, Retaining, and Advancing), showcasing positive impacts on Consultant performance. LifeVantage also announced its 2024 Incentive Trip - an 8-day Alaskan cruise for top achievers from the US, Canada, Mexico, and Europe. The event included comprehensive sales training sessions led by top leaders, providing strategies aligned with Rise ERA principles.
LifeVantage (Nasdaq: LFVN) announced that its President and CEO, Steve Fife, and CFO, Carl Aure, will participate in two investor conferences in June 2024. They will present at the Water Tower Research Consumer Products Virtual Investor Conference on June 5 at 11:00 am ET, and the MicroCap Rodeo – Spring Into Summer Conference on June 6 at 2:00 pm ET in New York City. Both presentations will be available via live webcast and for replay on LifeVantage’s Investor Relations website for approximately 90 days.
LifeVantage (LFVN) will participate in the Sidoti Micro Cap Conference on May 8-9, 2024. The President, CEO, and CFO will present to investors. The webcast will be available on the company's Investor Relations website.
LifeVantage (Nasdaq:LFVN) declared a quarterly cash dividend of $0.04 per share, reflecting a 14.3% increase from the previous quarter. The dividend will be paid on June 14, 2024, to stockholders of record as of May 31, 2024.
LifeVantage reported financial results for the third quarter of Fiscal 2024 with revenue of $48.2 million, a 10.2% decrease from the prior year. Adjusted EBITDA increased by 54.7% to $5.1 million. Despite revenue declines in the Americas and Asia/Pacific & Europe, positive trends were seen in operating margins and productivity gains. The company repurchased shares and announced a cash dividend of $0.04 per share. Fiscal Year 2024 guidance projects revenue of $202-$205 million and adjusted EBITDA of $16-$18 million.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.